Cowpox
📧 Sign up to get email alerts when something new happens for Cowpox.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-15EMA Authorised: Tecovirimat SIGA (tecovirimat) — SIGA Technologies Netherlands B.V.
The EMA authorized tecovirimat (SIGA) for multiple poxvirus infections, including monkeypox and smallpox, under the marketing authorization …
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses. [Phase 1]
Early-phase Phase 1 trial to evaluate the safety, tolerability, and pharmacokinetics of BSY001 after single and multiple doses; currently re…
-
EMA approval · 2025-11-10EMA Authorised: Tecovirimat SIGA (tecovirimat) — SIGA Technologies Netherlands B.V.
The EMA authorised tecovirimat (brand SIGA) for treatment of orthopoxvirus infections including cowpox, monkeypox, vaccinia infection, and s…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years [Phase 2, Phase 3]
Phase 2/3 trial evaluating immunogenicity, reactogenicity, and safety of the VACΔ6 vaccine in adults 18-60; study completed.